Device Identifier Management
Device identifier assignment and versioning are managed as master data, since identifiers change with device modifications and history must remain reconstructable.
UDI systems manage unique device identifiers across labeling, GUDID submission, and downstream documentation. The device identifier is master data feeding regulatory submission, hospital inventory, and patient records simultaneously, so accuracy at the source determines whether every downstream use is correct or confidently wrong.
UDI implementation is frequently treated as a labeling project when it is actually a master data problem. Taction Software builds medical device UDI system capability where identifier governance comes first, because a device identifier propagates into GUDID, distributor systems, hospital inventory, and eventually patient records, and correcting it later means correcting it everywhere.

Our experts are ready to understand your business goals.






























































A medical device UDI system manages unique device identification across the product lifecycle: assigning device identifiers through an accredited issuing agency, maintaining production identifiers, generating compliant labeling, submitting and updating records in the Global UDI Database, and supporting downstream documentation in hospital and clinical systems. Under FDA rules, identifiers must appear on labels and packages and be submitted to GUDID with defined attributes. Our work sits within our broader medical devices and IoT practice.
Device identifier assignment and versioning are managed as master data, since identifiers change with device modifications and history must remain reconstructable.
GUDID submission handles record creation, updates, and validation against FDA requirements, with submission approved by regulatory rather than automated.
UDI labeling generates compliant carriers in both human-readable and AIDC form, meeting the format requirements applicable to each device class.
Production identifiers covering lot, serial, expiry, and manufacture date are managed alongside device identifiers where the device requires them.
Attribute governance maintains the defined data elements GUDID requires, since incomplete or inconsistent attributes cause submission rejection.
UDI supports device documentation in clinical systems, integrating through our HL7 integration services work where implantable devices are recorded.
Our medical device UDI system services cover identifier governance, GUDID integration, labeling systems, data management, and downstream integration. The failure mode we design against is fragmentation: UDI data maintained separately in regulatory, labeling, and ERP systems drifts apart, and the resulting inconsistencies surface as submission rejections or field confusion. Engagements typically open with a review of where device data currently lives and how consistently it agrees.
We build master data governance so device attributes are maintained once and propagate, rather than being re-entered across regulatory, labeling, and ERP systems.
GUDID integration handles submission, update, and validation, with error handling since rejected records must be corrected and resubmitted rather than assumed filed.
Integration with labeling systems ensures carrier generation matches submitted data, preventing the mismatch between label and database that inspections find.
Integration spans enterprise systems, drawing on our enterprise application integration practice for data flow across functions.
Where devices include software, our FDA SaMD compliance services practice covers IEC 62304 lifecycle and classification requirements.
UDI supports distribution traceability, connecting with our supply chain management work for distribution visibility.
The benefits concentrate in submission accuracy, data consistency, and downstream usability. Manufacturers frequently maintain UDI data in spreadsheets feeding manual GUDID entry, which produces both submission errors and inconsistency between the label and the database. We publish no figures on submission acceptance, compliance improvement, or efficiency, because those depend entirely on portfolio size and current data maturity.
Master data governance eliminates the drift between regulatory, labeling, and ERP records that produces submission rejections and field confusion.
Validation before submission and explicit error handling reduce rejected records, which otherwise sit uncorrected because nobody monitored the response.
Generating carriers from the same source as submitted data prevents mismatches between physical labels and the GUDID record.
Automating submission reduces the manual GUDID work that scales poorly across portfolios with many device configurations and versions.
Accurate UDI improves hospital inventory and clinical documentation, supporting our medical device inventory work on the provider side.
Reliable identifier data supports field action execution, since recalls depend on knowing exactly which devices went where.
We deliver medical device UDI system projects in gated phases so regulatory, quality, and IT stakeholders approve direction before engineering cost accumulates. Discovery establishes portfolio scope, current data quality, and where device attributes disagree across systems. Data reconciliation precedes automation, because automating submission from inconsistent source data produces rejected records faster rather than fewer. Where the device includes software, IEC 62304 classification is confirmed early.
Discovery evaluates device data consistency across systems, since automating submission from conflicting sources produces errors at greater speed.
We design attribute governance defining authoritative source for each data element, since multiple owners of one attribute guarantees divergence.
Submission workflow includes validation, approval, and response handling, so rejected records are corrected rather than silently unfiled.
Label generation is driven from the same master data as submission, eliminating the divergence that separate maintenance inevitably produces.
Regulatory affairs reviews submission content before transmission, since GUDID records are regulatory statements rather than operational data entries.
Rollout expands by product family with data quality monitoring and continuing support as devices change and requirements evolve.
UDI systems operate under FDA unique device identification requirements including GUDID submission and labeling obligations, with parallel requirements in other jurisdictions including EUDAMED in the European Union. Where the device includes software, IEC 62304 governs the software lifecycle and applies to safety classification, and quality system requirements under 21 CFR Part 820 apply to the manufacturer. Taction holds ISO 27001 certification. UDI data is generally product data rather than PHI, though downstream clinical use introduces patient context.
UDI rules govern identifier format, labeling, and GUDID submission, with requirements varying by device class and compliance date.
Where the device contains software, IEC 62304 governs lifecycle processes and safety classification, which we follow for device software components.
Quality system requirements apply to design and change control, so UDI system changes affecting labeling follow controlled processes.
EUDAMED and other jurisdictional systems impose parallel obligations with differing attributes, requiring data models that accommodate both.
UDI is product data, not PHI, though downstream clinical documentation introduces patient context. Our HIPAA compliance practice covers that boundary.
Deployments run in your cloud tenancy or hybrid, with network segmentation, signed container images, and documented penetration testing before release.
Taction Software was founded in 2013 and has spent over 12 years building healthcare and life sciences software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. Our relevant judgment here is treating UDI as master data rather than a labeling task. Manufacturers who approach it as labeling produce compliant labels and inconsistent databases, which surfaces during inspection or recall. Our leadership brings more than 20 years of personal experience in the field.
We govern device attributes as master data with defined ownership, since fragmented maintenance guarantees divergence between label and database.
We delivered the FDA-registered applications Revive Ease and PainKare, so design controls and validation documentation are established practice.
Founded in 2013, we have concentrated on healthcare and life sciences rather than treating them as one vertical among several.
Our hospital inventory and clinical systems work means we understand how UDI is consumed downstream, not only how it is submitted.
Our work spans regulatory, labeling, and ERP systems, which UDI data must traverse consistently to be useful rather than merely filed.
ISO 27001 certification means security controls are documented and auditable, supporting manufacturer vendor assessment efficiently.
Medical device UDI system pricing depends on portfolio size, current data quality, integration breadth, and whether international requirements are in scope. Data reconciliation across existing systems is frequently the largest effort, ahead of submission automation itself. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown. Issuing agency fees, labeling software licensing, and cloud infrastructure are separate from engineering cost and itemized clearly.
An MVP covering GUDID submission workflow for one product family typically runs $40,000 to $80,000.
A full platform with master data governance, submission, labeling integration, and ERP connectivity typically falls between $80,000 and $200,000.
Enterprise engagements covering large portfolios, international requirements, and full systems integration start at $200,000.
Discovery is a paid, time-boxed phase producing an itemized estimate, architecture plan, and device data quality assessment.
Data reconciliation, portfolio size, international scope, and integration count are the largest variables, identified during discovery.
Post-launch requirement changes, new product onboarding, and support are quoted separately as a retainer sized to portfolio breadth.
If you are evaluating a medical device UDI system for GUDID submission, identifier governance, labeling integration, or international compliance, the fastest next step is a discovery call with our team. We will assess device data quality across your systems and return an itemized, fixed-scope estimate. Contact us to schedule that conversation.
Regulatory and quality leaders evaluating medical device UDI system development usually ask why UDI is harder than it appears, how GUDID rejections are handled, and whether international requirements can share one system. The answers below reflect how we scope these projects.
Because the identifier is master data feeding GUDID, labeling, ERP, distribution, and eventually patient records. Organizations that treat it as a labeling task end up with compliant labels and a database that disagrees with them, which surfaces during inspection or when a recall requires knowing exactly what shipped.
It needs correction and resubmission, which requires someone monitoring responses. Rejected records that nobody noticed are a common finding, since manual submission processes frequently lack response handling. We build explicit error surfacing so rejections become actionable exceptions rather than silent gaps.
With a data model designed for it, largely yes, though attribute requirements differ and cannot simply be mapped one to one. We design for both where international scope exists, rather than building for FDA and retrofitting European requirements later, which is more expensive.
An MVP covering submission for one product family runs $40,000 to $80,000. A full platform typically falls between $80,000 and $200,000. Enterprise deployments with international scope start at $200,000. Data reconciliation drives cost more than portfolio size alone.
Generally not, since a UDI management system is business software rather than device software. IEC 62304 applies to software that is part of the medical device or is itself a device. We assess that boundary explicitly, since it changes development obligations substantially.
Through clinical system documentation, typically at implantation for implantable devices. Hospitals capture the identifier into the record, which depends on the identifier being scannable and the data being accurate. That downstream usability is why source data quality matters beyond the submission itself.
Your email address will not be published. Required fields are marked *
Our expert reaches out shortly after receiving your request and analyzing your requirements.
If needed, we sign an NDA to protect your privacy.
We request additional information to better understand and analyze your project.
We schedule a call to discuss your project, goals. and priorities, and provide preliminary feedback.
If you're satisfied, we finalize the agreement and start your project.